Cyclosporine-A incorporated cationic solid lipid nanoparticles for ocular delivery

In the present study, Cyclosporine A was successfully incorporated into cationic solid lipid nanoparticles for ocular application

Ebru Başaran

2010

Scholarcy highlights

  • In the present study, Cyclosporine A was successfully incorporated into cationic solid lipid nanoparticles for ocular application
  • Cyclosporine A was successfully incorporated into cationic solid lipid nanoparticles for ocular application
  • Physicochemical characterizations of SLNs were analysed in detail during the storage period
  • 200 µL of formulation was applied to sheep' eyes under veterinarian supervision
  • Samples were collected at pre-determined time intervals
  • vitreous humour samples for 48 h showing the ocular penetration of formulation
  • You are consenting to our use of cookies

Need more features? Save interactive summary cards to your Scholarcy Library.